Sotera Health (SHC) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SHC shares.
View SHC analyst ratings or view top-rated stocks.

7 brokers have issued 12 month price objectives for Sotera Health's stock. Their SHC share price forecasts range from $8.00 to $25.00. On average, they expect the company's share price to reach $17.86 in the next twelve months. This suggests a possible upside of 17.0% from the stock's current price.
View analysts price targets for SHC or view top-rated stocks among Wall Street analysts.

Sotera Health's stock was trading at $8.33 on January 1st, 2023. Since then, SHC shares have increased by 83.2% and is now trading at $15.26.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our SHC earnings forecast.

Sotera Health (NASDAQ:SHC) released its earnings results on Thursday, August, 3rd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.02. The firm had revenue of $255.28 million for the quarter, compared to analyst estimates of $261.05 million. Sotera Health had a positive trailing twelve-month return on equity of 48.61% and a negative net margin of 27.48%.

ETFs with the largest weight of Sotera Health (NASDAQ:SHC) stock in their portfolio include Adaptiv Select ETF (ADPV), WisdomTree U.S. SmallCap Fund (EES) and iShares Emergent Food and AgTech Multisector ETF (IVEG).Invesco S&P MidCap 400 GARP ETF (EWMC).

Sotera Health issued an update on its FY23 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $0.78-$0.86 for the period, compared to the consensus EPS estimate of $0.80. The company issued revenue guidance of $1.035-$1.055 billion, compared to the consensus revenue estimate of $1.07 billion.

(SHC) raised $1 billion in an IPO on Friday, November 20th 2020. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets served as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

Sotera Health trades on the NASDAQ under the ticker symbol "SHC."

Sotera Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.39%), ArrowMark Colorado Holdings LLC (1.80%), MIG Capital LLC (1.29%), State Street Corp (0.96%), Schroder Investment Management Group (0.96%) and Hawk Ridge Capital Management LP (0.79%). Insiders that own company stock include Matthew J Klaben, Michael B Jr Petras, Michael P Rutz and Pincus & Co Warburg.
View institutional ownership trends.

Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SHC stock can currently be purchased for approximately $15.26.

Sotera Health (NASDAQ:SHC) has a market capitalization of $4.31 billion and generates $1.00 billion in revenue each year. The company earns $-233,570,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis.

The company employs 3,000 workers across the globe.

Sotera Health's mailing address is 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147. The official website for the company is www.soterahealth.com. The company can be reached via phone at 440-262-1410 or via email at ir@soterahealth.com.